COMMUNIQUÉS West-GlobeNewswire

Delcath Announces Ratio for Reverse Split Authorization
01/05/2018
NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Company’s Board of [...]
Release date of three-month interim report (Q1) 2018 and audio cast
01/05/2018
On Friday, 4 May 2018, ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) releases its interim report for the three months ended 31 March 2018. ALK will host a meeting for analysts and institutional investors that day at 1.30 [...]
Endonovo Therapeutics Highlights Feasibility Study Results of Its Electroceutical Therapy in Reducing Proteinuria in Chronic Kidney Disease Patients
01/05/2018
Company to Conduct Larger Clinical Study to Evaluate Its Electroceutical™ Therapy in Chronic Kidney Disease LOS ANGELES, CA, May 01, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the [...]
Spark Therapeutics to Host Conference Call on Tuesday, May 8 at 8:30 a.m. ET to Discuss First Quarter Results and Recent Business Highlights
01/05/2018
PHILADELPHIA, May 01, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE ), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, will host a conference call on [...]
Kura Oncology to Report First Quarter 2018 Financial Results
01/05/2018
SAN DIEGO, May 01, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA ), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that it will [...]
Epizyme Announces First Quarter 2018 Financial Reporting Date and Upcoming Conference Call
01/05/2018
First Quarter 2018 Financial Results to be Announced May 8, 2018 Investor Conference Call to be Scheduled for May 17, 2018 to Discuss Updated Interim Data from Tazemetostat Trials CAMBRIDGE, Mass., May 01, 2018 (GLOBE [...]
FDA Releases Theratechnologies from Post-Approval Commitments Related to EGRIFTA® (Tesamorelin for Injection)
01/05/2018
MONTREAL, May 01, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH ) today announced that the Food and Drug Administration (FDA) has released Theratechnologies from post-approval commitments [...]
La FDA dégage Theratechnologies de ses obligations post-approbation en lien avec EGRIFTA(MD) (tésamoréline pour injection)
01/05/2018
MONTRÉAL, 01 mai 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH ) a annoncé aujourd’hui que la Food and Drug Administration (FDA) dégage Theratechnologies de ses obligations post- [...]
KemPharm, Inc. to Report First Quarter 2018 Results
01/05/2018
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for May 10, 2018, 4:30 p.m. ET CORALVILLE, Iowa, May 01, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH ), a specialty pharmaceutical [...]
Scythian Biosciences Announces Extension of Letter of Intent
01/05/2018
TORONTO, May 01, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSX-V: SCYB ) (Frankfurt: 9SB ) (OTC – Nasdaq Intl:SCCYF) announced today that the Company has signed an agreement [...]
NanoVibronix to Present at the 3rd Annual Disruptive Growth & Healthcare Conference Hosted by RHK Capital and Reed Smith
01/05/2018
NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV ), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today [...]
Ultragenyx to Host Conference Call for First Quarter 2018 Financial Results and Corporate Update
01/05/2018
NOVATO, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced [...]
Profound Medical Further Strengthens Management Team with Appointment of Aaron Davidson as Chief Financial Officer and Senior Vice-President of Corporate Development
01/05/2018
TORONTO, May 01, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]
Body Count: Canadians with curable illnesses are dying every day without pharmacare, according to a new study from Canada’s nurses
01/05/2018
OTTAWA, May 01, 2018 (GLOBE NEWSWIRE) -- Canada’s nurses unveiled a new study today – the first of its kind in Canada – that reveals the number of people in Canada who die or fall ill because prescription medications [...]
Comptons les corps : Selon une nouvelle étude commandée par le personnel infirmier du Canada, des personnes atteintes de maladies curables meurent à chaque jour au pays en l’absence de régime universel d’assurance-médicaments
01/05/2018
OTTAWA, 01 mai 2018 (GLOBE NEWSWIRE) -- Le personnel infirmier du Canada a communiqué, aujourd’hui, une nouvelle étude – la première de ce genre au Canada – qui révèle le nombre de personnes au pays qui meurent ou [...]
Maple Leaf Begins Interior Construction on its Telkwa, British Columbia Facility
01/05/2018
CALGARY, Alberta, May 01, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) (NEO: MGW ) (OTCQB:MGWFF) is pleased to announce that it has received a progress report from the Company [...]
COCRYSTAL PHARMA, INC., PRICES $8,000,000 COMMON STOCK OFFERING
01/05/2018
TUCKER, GA and BOTHELL, WA, May 01, 2018 (GLOBE NEWSWIRE) -- COCRYSTAL PHARMA, INC. (NASDAQ: COCP) , (“Cocrystal” or the “Company”) a clinical stage biotechnology company focused on developing innovative antiviral [...]
Marrone Bio Innovations to Present at 3rd Annual RHK Capital Disruptive Growth & Healthcare Conference in New York on May 8th
01/05/2018
DAVIS, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental and [...]
Advanced Proteome Therapeutics Updates its Activities During the 3rd Quarter, FY 2018
01/05/2018
VANCOUVER, British Columbia, May 01, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“ APC ” or the “ Company ”) (TSXV:APC) (FSE:0E8) is pleased to provide an update of progress during the third [...]

Pages